Synthesis of a Naturally Compatible Solute
4.92 mmol) was added to a solution of 2[10] (0.634 g, 1.64 mmol) in
dry DMF (5 mL) at room temperature, followed by imidazole
(0.391 g, 5.74 mmol). After 12 h at room temperature, the reaction
was quenched with H2O (5 mL), extracted with CH2Cl2 (3ϫ5 mL),
and the combined organic phases were dried (MgSO4) and concen-
trated. Purification by flash column chromatography on silica gel
(30:70 EtOAc/hexane) afforded the product 4 as a white solid
4.29–4.18 (m, 3 H), 3.97 (dd, J = 5.4, 10.5 Hz, 1 H), 3.91–3.83 (m,
2 H), 3.80–3.71 (m, 4 H), 3.72 (s, 3 H), 3.28 (s, 3 H), 3.17 (s, 3 H),
2.17 (s, 3 H), 2.13 (s, 3 H), 2.04 (s, 3 H), 1.97 (s, 3 H), 1.27 (s, 6
H), 1.01 (s, 9 H), 1.00 (s, 9 H) ppm. 13C NMR (CDCl3): δ = 170.7,
170.3, 169.8, 169.6, 169.5, 135.8, 135.6, 135.5, 135.4, 133.7, 133.2,
132.7, 129.8, 129.7, 129.6, 129.5, 127.8, 127.7, 127.5, 127.4, 99.6,
99.5, 94.6 [C-1(α) mannose], 93.9 [C-1(α) glucose], 74.6, 70.9, 70.4,
69.6, 69.1, 68.5, 67.8, 66.3, 65.8, 64.4, 62.3, 61.7, 51.9, 47.9, 47.8,
26.7, 26.5, 20.9, 20.7, 20.69, 20.67 19.3, 19.1, 17.6, 17.6 ppm.
C62H82O20Si2 (1203.49): calcd. C 61.88, H 6.87; found C 61.90, H
(0.908 g, 89%). [α]2D0 = +34.1 (c = 0.17, CH2Cl2). M.p. 69.2–71.4 °C.
1
FTIR (film): ν = 3496 (O–H) cm–1. H NMR (CDCl ): δ = 7.67–
˜
3
7.72 (m, 4 H), 7.57–7.55 (m, 2 H), 7.42–7.31 (m, 6 H), 7.23–7.19
(m, 3 H), 4.57 [d, J = 9.3 Hz, 1 H, 1-H(β)], 3.99–3.90 (m, 2 H), 6.75.
3.82–3.73 (m, 2 H), 3.59–3.52 (m, 2 H), 3.31 (s, 3 H), 3.19 (s, 3 H),
Methyl (2R)-2-O-[2,3,4,6-Tetra-O-acetyl-α-
(1Ǟ2)-3,4-di-O-(2,3-dimethoxybutane-2,3-diyl)-1-O-α-
D
-mannopyranosyl-
-glucopyr-
1.33 (s, 3 H), 1.28 (s, 3 H), 1.06 (s, 9 H) ppm. 13C NMR (CDCl3):
δ = 135.8, 135.5, 133.7, 133.1, 132.8, 131.9, 129.6, 129.5, 129.0,
127.9, 127.66, 127.63, 99.7, 99.4, 88.5 [C-1(β)], 78.9, 73.7, 69.1,
64.9, 61.9, 48.2, 48.0, 26.9, 19.3, 17.7, 17.6 ppm. C34H44O7SSi
(624.86): calcd. C 65.35, H 7.10, S 5.13; found C 65.00, H 6.86, S
5.01.
D
anosyl]-2,3-dihydroxypropanoate (9): TBAF (1 m in THF; 0.22 mL,
0.22 mmol) was added to a solution of 8 (0.246 g, 0.20 mmol) in
THF (3 mL) at room temperature. The reaction mixture was stirred
for 3 h and then water was added. The mixture was extracted with
EtOAc, dried (MgSO4) and concentrated to give a yellow viscous
residue. Purification by column chromatography (EtOAc) afforded
product 9 as a viscous colorless foam (0.103 g, 71%). [α]2D0 = +155.2
Phenyl 2,3,4,6-Tetra-O-acetyl-α-
butyldiphenylsilyl-3,4-di-O-(2,3-dimethoxybutane-2,3-diyl)-1-thio-β-
-glucopyranoside (6): Acceptor 4 (0.254 g, 0.41 mmol) was added
D-mannopyranosyl-(1Ǟ2)-6-O-tert-
D
(c = 1.82, CH Cl ). FTIR (film): ν = 3463 (O–H), 1747, 1636
˜
2
2
(C=O) cm–1. 1H NMR (CDCl3): δ = 5.39–5.37 (m, 1 H), 5.35–5.28
(m, 2 H), 5.19 [d, J = 3.8 Hz, 1 H, C-1(α) glucose], 5.13 [s, 1 H, C-
1(α) mannose], 4.50–4.48 (m, 1 H), 4.39–4.36 (m, 1 H), 4.26–4.17
(m, 2 H), 4.10 (t, J = 10.0 Hz, 1 H), 3.95–3.81 (m, 5 H), 3.75–3.67
(m, 2 H), 3.73 (s, 3 H), 3.34 (s, 3 H), 3.24 (s, 3 H), 2.17 (s, 3 H),
2.13 (s, 3 H), 2.04 (s, 3 H), 1.98 (s, 3 H), 1.30 (s, 3 H), 1.26 (s, 3
H) ppm. 13C NMR (CDCl3): δ = 170.7, 170.1, 169.9, 169.74,
169.70, 99.8, 99.7, 94.9 [C-1(α) mannose], 94.6 [C-1(α) glucose],
75.4, 71.4, 70.0, 69.3, 69.2, 68.7, 67.4, 66.0, 65.8, 63.3, 62.1, 60.9,
52.2, 47.9, 47.8, 20.8, 20.7, 17.6, 17.5 ppm. HRMS: calcd. for
C30H46O20Na+ [M+ + Na] 749.2475; found 749.2451.
to a solution of trichloroacetamidate 5 (0.250 g, 0.51 mmol) in dry
CH2Cl2 (4 mL). The solution was cooled to –20 °C and TMSOTf
(92.30 μL, 0.51 mmol) was slowly added. When the reaction was
completed, a saturated aqueous solution of NaHCO3 (2 mL) was
added, followed by extractions with CH2Cl2. The combined organic
phases were dried (MgSO4) and concentrated. The residue was
purified by flash column chromatography on silica gel (20:80
EtOAc/hexane) to afford 6 as a white foam (0.237 g, 58%). [α]2D0
=
+54.15 (c = 1.30, CH Cl ). FTIR (film): ν = 1752 (C=O) cm–1. 1H
˜
2
2
NMR (CDCl3): δ = 7.73–7.70 (m, 4 H), 7.55–7.53 (m, 2 H), 7.43–
7.19 (m, 9 H), 5.51 [s, 1 H, 1-H(α) mannose], 5.35–5.33 (m, 3 H),
4.73–4.72 (m, 1 H), 4.65 [d, J = 8.7 Hz, 1 H, 1-H(β) glucose], 4.29
(dd, J = 3.6, 12.0 Hz, 1 H), 4.18–4.15 (m, 1 H), 3.95–3.88 (m, 2
H), 3.79–3.76 (m, 3 H), 3.32 (s, 3 H), 3.17 (s, 3 H), 2.20 (s, 3 H),
2.12 (s, 3 H), 2.01 (s, 3 H), 1.99 (s, 3 H), 1.26 (s, 3 H), 1.25 (s, 3
H), 1.06 (s, 9 H) ppm. 13C NMR (CDCl3): δ = 170.8, 169.9, 169.8,
169.6, 135.8, 135.5, 133.9, 133.6, 133.0, 131.9, 131.5, 129.6, 129.5,
129.0, 127.6, 127.5, 99.9, 99.3, 97.1 [C-1(α) mannose], 88.7 [C-1(β)
glucose], 78.5, 73.4, 72.8, 69.2, 69.1, 68.6, 66.0, 65.1, 62.0, 48.0,
47.9, 26.8, 20.9, 20.71, 20.70, 20.6, 19.3, 17.6, 17.3 ppm.
C48H62O16SSi (955.15): calcd. C 60.36, H 6.54; found C 60.50, H
6.40.
Methyl (2R)-2-O-[2,3,4,6-Tetra-O-acetyl-α-
D-mannopyranosyl-
(1Ǟ2)-1-O-α- -glucopyranosyl]-2,3-dihydroxypropanoate (10): A
D
mixture of TFA/H2O (5:1) (0.8 mL) was added to a solution of 9
(0.093 g, 0.13 mmol) in CH2Cl2 (1 mL) at room temperature. The
reaction mixture was stirred until all of the starting material had
been consumed and then it was concentrated to give a viscous resi-
due. Purification by column chromatography (1:4, MeOH/CH2Cl2)
afforded product 10 as a viscous colorless foam (0.055 g, 70%).
[α]2D0 = +72.17 (c = 0.46, EtOH). FTIR (film): ν = 3460 (O–H),
˜
1748 (C=O) cm–1. 1H NMR (CDCl3): δ = 5.43–5.42 (m, 1 H), 5.38
(dd, J = 3.2, 10.0 Hz, 1 H), 5.26 (t, J = 10.0 Hz, 1 H), 5.20 [d, J =
3.6 Hz, 1 H, 1-H(α) glucose], 5.17 [d, J = 1.4 Hz, 1 H, 1-H(α) man-
nose], 4.48 (t, J = 4.2 Hz, 1 H), 4.46–4.39 (m, 2 H), 4.15–4.12 (m,
1 H), 3.88–3.68 (m, 7 H), 3.69 (s, 3 H), 3.43 (t, J = 9.4 Hz, 1 H),
2.18 (s, 3 H), 2.09 (s, 3 H), 2.06 (s, 3 H), 1.98 (s, 3 H) ppm. 13C
NMR (CDCl3):δ = 173.7, 173.1, 172.8, 172.7, 172.0, 95.4 [C-1(α)
mannose], 94.8 [C-1(α) glucose], 75.9, 75.4, 72.2, 70.9, 69.7, 69.3,
68.4, 65.5, 62.3, 61.8, 60.3, 52.7, 20.1, 20.0 ppm. HRMS: calcd. for
C24H36O18Na+ [M+ + Na] 635.1794; found 635.2451.
Methyl 3-O-tert-Butyldiphenylsilyl-(2R)-2-O-[2,3,4,6-tetra-O-
acetyl-α-
D
-mannopyranosyl-(1Ǟ2)-6-O-tert-butyldiphenylsilyl-3,4-
-glucopyranosyl]-2,3-di-
di-O-(2,3-dimethoxybutane-2,3-diyl)-1-O-α-
D
hydroxypropanoate (8): A suspension of thioglycoside 6 (0.387 g,
0.40 mmol), glycerate 7 (0.143 g, 0.40 mmol) and 4 Å molecular si-
eves in CH2Cl2 (3 mL) was stirred at room temperature for 1 h.
The solution was cooled to 0 °C and N-iodosuccinimide (0.099 g,
0.44 mmol) and TMSOTf (36 μL, 0.20 mmol) were added. After all
of the starting material had been consumed, a 10% aqueous solu-
tion of Na2S2O3 (2 mL) and a saturated aqueous solution of
NaHCO3 (1 mL) were added and the mixture was extracted with
CH2Cl2; the combined organic phases were dried (MgSO4), filtered
and the solvent was removed in vacuo. The crude product was puri-
fied by column chromatography (30:70 EtOAc/hexane) to afford
Methyl (2R)-2-O-[α-D-Mannopyranosyl-(1Ǟ2)-1-O-α-D-glucopyr-
anosyl]-2,3-dihydroxypropanoate (11): A 1 n solution of NaOMe
(34 μL, 0.03 mmol) in MeOH was added to a stirred solution of 10
(0.036 g, 0.06 mmol) in MeOH (1 mL) at 0 °C. After 1 h, previously
activated Dowex-H+ resin was added until the pH of the reaction
mixture reached 7. After filtration with MeOH and water, the sol-
glycoside 8 as a colorless viscous foam (0.286 g, 60%). [α]2D0 = +83.3
1
(c = 1.00, CH Cl ). FTIR (film): ν = 1641, 1753 (C=O) cm–1. H
vent was removed in vacuo to yield 11 as a viscous colorless foam
˜
2
2
1
NMR (CDCl3): δ = 7.68–7.62 (m, 8 H), 7.42–7.30 (m, 12 H), 5.46 (0.026 g, quantitative). [α]2D0 = +135.61 (c = 2.03, H2O). H NMR
(dd, J = 3.4, 9.9 Hz, 1 H), 5.40–5.39 (m), 5.29 (t, J = 10.0 Hz, 1
H), 5.20 [d, J = 1.4 Hz, 1 H, C-1(α) mannose], 5.13 [d, J = 3.8 Hz,
1 H, C-1(α) glucose], 4.52–4.48 (m, 1 H), 4.37 (dd, J = 5.2, 3.8 Hz),
(D2O): δ = 5.26 [d, J = 3.4 Hz, 1 H, 1-H(α) glucose], 5.09 [d, J =
1.3 Hz, 1 H, 1-H(α) mannose], 4.52 (t, J = 3.8 Hz, 1 H), 4.03 (q, J
= 1.6 Hz, 1 H), 3.91–3.90 (m, 2 H), 3.87–3.63 (m, 10 H), 3.77 (s, 3
Eur. J. Org. Chem. 2011, 6698–6703
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
6701